Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate-to-severe glabellar lines: A non-inferiority double blinded randomized controlled trial.

Seyyedeh Maryam AfshaniAnsieh SamadiAzin AyatollahiMansour Nassiri KashaniSaman Ahmad NasdrollahiHamed HosseiniZahra RezagholiBehnaz HedayatjooDelara Hazegh FetratjooMohammad Amin GhobadiAmirHossein AnariSajjad SaeedifarAlireza Firooz

Published in: Journal of cosmetic dermatology (2022)

Keyphrases

randomized controlled trial
escherichia coli
study protocol
high intensity
early onset
clinical trial
drug induced